Agenus to provide corporate update and second quarter 2025 financial report

Lexington, mass.--(business wire)--agenus inc. (“agenus”) (nasdaq: agen), a leader in immuno-oncology, today announced that the company will release its second quarter 2025 financial results before the market opens on monday, august 11, 2025. agenus will then host a stakeholder briefing in late august to spotlight key strategic plans, data milestones and provide a comprehensive update on the global botensilimab (bot) and balstilimab (bal) development program. about agenus agenus is a leading im.
AGEN Ratings Summary
AGEN Quant Ranking